Who we are
Innovative Biopharmaceutical Association (IBA) - USA is a nonprofit organization home-based in Greater Philadelphia and dedicated to advancing the communication, translation, and commercialization of cutting-edge scientific discoveries and pharmaceutical R&D innovations. IBA primarily serves U.S.-based academic investigators and biopharmaceutical companies, with a mission to build a high-level national platform that fosters drug development through active engagement of scientists, clinical experts, entrepreneurs, and venture capital partners across the United States.
Leadership Team
IBA Founding Executive Committee
Dr. Ling Yang
Associate Professor
Temple University
Dr. Qing Liang
Founder, Neulink Pharmaceuticals
CEO, NexStage Bio
Dr. Yue Zhu
Senior Director, Global Clinical Development
BioNTech
Dr. Mei Wang
EVP, Global Sales & Marketing & Project Management
Frontage Laboratories